June 13, 2019
Although biobanks around the world have since amassed millions of human biospecimens, and valuable insights have been extracted from them, the biospecimen procurement challenge is holding firm. Recently, iSpecimen launched a survey of its own, recasting several questions similar to those included in the aforementioned OBBR survey, to take a pulse on potential improvements related to the availability of quality specimens.
June 6, 2019
Learn more about our Chief Operating Officer, Jill Mullan.
|